Clinical Trial Update: Optical Frequency Domain Imaging (OFDI) in Dermatology

View source ↗

Summary

A clinical trial evaluating Optical Frequency Domain Imaging (OFDI) for Port-wine stain in dermatology has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Port-wine Stain

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Port Wine Stain | Status: WITHDRAWN